Current and historical daily PE Ratio for FMS (
Fresenius Medical Care AG
) from 1996 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Fresenius Medical Care AG stock (FMS) PE ratio as of Apr 28 2024 is 22.01.
More Details
Fresenius Medical Care AG (FMS) PE Ratio (TTM) Chart
Fresenius Medical Care AG (FMS) PE Ratio (TTM) Historical Data
View and export this data going back to 1996. Start your Free Trial
Total 1217
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Fresenius Medical Care AG PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-28 | 21.9 | 2024-02-23 | 21.1 |
| 2024-04-26 | 21.9 | 2024-02-22 | 21.3 |
| 2024-04-25 | 22.0 | 2024-02-21 | 21.0 |
| 2024-04-24 | 22.6 | 2024-02-20 | 22.4 |
| 2024-04-23 | 23.4 | 2024-02-16 | 23.0 |
| 2024-04-22 | 22.4 | 2024-02-15 | 22.9 |
| 2024-04-19 | 21.3 | 2024-02-14 | 23.1 |
| 2024-04-18 | 21.1 | 2024-02-13 | 21.9 |
| 2024-04-17 | 20.6 | 2024-02-12 | 21.8 |
| 2024-04-16 | 20.2 | 2024-02-09 | 21.3 |
| 2024-04-15 | 20.4 | 2024-02-08 | 21.4 |
| 2024-04-12 | 20.0 | 2024-02-07 | 21.4 |
| 2024-04-11 | 20.6 | 2024-02-06 | 21.6 |
| 2024-04-10 | 20.8 | 2024-02-05 | 21.1 |
| 2024-04-09 | 20.9 | 2024-02-02 | 21.0 |
| 2024-04-08 | 20.6 | 2024-02-01 | 21.4 |
| 2024-04-05 | 20.4 | 2024-01-31 | 21.0 |
| 2024-04-04 | 20.4 | 2024-01-30 | 21.1 |
| 2024-04-03 | 20.5 | 2024-01-29 | 21.9 |
| 2024-04-02 | 20.4 | 2024-01-26 | 21.8 |
| 2024-04-01 | 20.8 | 2024-01-25 | 21.6 |
| 2024-03-28 | 21.0 | 2024-01-24 | 21.7 |
| 2024-03-27 | 21.1 | 2024-01-23 | 21.3 |
| 2024-03-26 | 20.6 | 2024-01-22 | 21.4 |
| 2024-03-25 | 20.6 | 2024-01-19 | 21.3 |
| 2024-03-22 | 20.4 | 2024-01-18 | 21.1 |
| 2024-03-21 | 20.7 | 2024-01-17 | 20.8 |
| 2024-03-20 | 21.4 | 2024-01-16 | 21.4 |
| 2024-03-19 | 21.3 | 2024-01-12 | 21.9 |
| 2024-03-18 | 20.7 | 2024-01-11 | 22.0 |
| 2024-03-15 | 20.7 | 2024-01-10 | 22.0 |
| 2024-03-14 | 21.4 | 2024-01-09 | 22.1 |
| 2024-03-13 | 21.9 | 2024-01-08 | 22.5 |
| 2024-03-12 | 21.9 | 2024-01-05 | 22.4 |
| 2024-03-11 | 21.8 | 2024-01-04 | 22.7 |
| 2024-03-08 | 22.1 | 2024-01-03 | 22.4 |
| 2024-03-07 | 22.5 | 2024-01-02 | 23.1 |
| 2024-03-06 | 21.8 | 2023-12-29 | 22.7 |
| 2024-03-05 | 22.6 | 2023-12-28 | 22.8 |
| 2024-03-04 | 20.3 | 2023-12-27 | 25.7 |
| 2024-03-01 | 21.1 | 2023-12-26 | 25.8 |
| 2024-02-29 | 20.9 | 2023-12-22 | 25.5 |
| 2024-02-28 | 21.0 | 2023-12-21 | 25.6 |
| 2024-02-27 | 21.4 | 2023-12-20 | 25.0 |
| 2024-02-26 | 21.4 | 2023-12-19 | 25.2 |
Fresenius Medical Care AG (FMS) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Fresenius Medical Care AG
NAICS : 621492
SIC : 8092
ISIN : US3580291066
Share Class Description:
FMS: ADRCompare
Compare
Traded in other countries / regions
FMS.USAFME.Germany0H9X.UKFME.Austria1FME.ItalyFMSC34.BrazilFME.Mexico IPO Date
1996-09-17Description
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers